179 related articles for article (PubMed ID: 22306346)
1. Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K+ induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats.
Escobar Adel P; Cornejo FA; Andrés ME; Fuentealba JA
Neurochem Int; 2012 Mar; 60(4):344-9. PubMed ID: 22306346
[TBL] [Abstract][Full Text] [Related]
2. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
Heidbreder CA; Schenk S; Partridge B; Shippenberg TS
Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
Escobar AP; González MP; Meza RC; Noches V; Henny P; Gysling K; España RA; Fuentealba JA; Andrés ME
Int J Neuropsychopharmacol; 2017 Aug; 20(8):660-669. PubMed ID: 28531297
[TBL] [Abstract][Full Text] [Related]
4. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
Fuentealba JA; Gysling K; Magendzo K; Andrés ME
J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
[TBL] [Abstract][Full Text] [Related]
5. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
6. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
Fuentealba JA; Gysling K; Andrés ME
Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
[TBL] [Abstract][Full Text] [Related]
7. Repeated treatment with the κ-opioid agonist U-69593 increases K+-stimulated dopamine release in the rat medial prefrontal cortex.
Fuentealba JA; Gysling K; Andrés ME
Synapse; 2010 Dec; 64(12):898-904. PubMed ID: 20939060
[TBL] [Abstract][Full Text] [Related]
8. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
[TBL] [Abstract][Full Text] [Related]
9. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
Perreault ML; Graham D; Bisnaire L; Simms J; Hayton S; Szechtman H
Neuropsychopharmacology; 2006 Sep; 31(9):1967-81. PubMed ID: 16237381
[TBL] [Abstract][Full Text] [Related]
10. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA
Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine locomotor sensitization is accompanied with an enhanced high K⁺-stimulated Dopamine release in the rat medial prefrontal cortex.
Casanova JP; Velis GP; Fuentealba JA
Behav Brain Res; 2013 Jan; 237():313-7. PubMed ID: 23047059
[TBL] [Abstract][Full Text] [Related]
12. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids.
Leitl MD; Onvani S; Bowers MS; Cheng K; Rice KC; Carlezon WA; Banks ML; Negus SS
Neuropsychopharmacology; 2014 Feb; 39(3):614-24. PubMed ID: 24008352
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
El Daly E; Chefer V; Sandill S; Shippenberg TS
J Neurochem; 2000 Apr; 74(4):1553-62. PubMed ID: 10737612
[TBL] [Abstract][Full Text] [Related]
14. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Perreault ML; Seeman P; Szechtman H
Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.
Shippenberg TS; LeFevour A; Thompson AC
Eur J Pharmacol; 1998 Mar; 345(1):27-34. PubMed ID: 9593590
[TBL] [Abstract][Full Text] [Related]
16. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Quarta D; Valerio E; Hutcheson DM; Hedou G; Heidbreder C
Neurochem Int; 2010 Jan; 56(1):11-5. PubMed ID: 19737591
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
18. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
Beerepoot P; Lam V; Luu A; Tsoi B; Siebert D; Szechtman H
Neurosci Lett; 2008 Dec; 446(2-3):101-4. PubMed ID: 18824069
[TBL] [Abstract][Full Text] [Related]
19. Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.
Xia YF; He L; Whistler JL; Hjelmstad GO
Neuropsychopharmacology; 2008 Mar; 33(4):892-900. PubMed ID: 17551543
[TBL] [Abstract][Full Text] [Related]
20. Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens.
David HN; Dhilly M; Degoulet M; Poisnel G; Meckler C; Vallée N; Blatteau JÉ; Risso JJ; Lemaire M; Debruyne D; Abraini JH
Transl Psychiatry; 2015 Jul; 5(7):e594. PubMed ID: 26151922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
